This work has received funding from the KU Leuven C1 program, the European Unionâ€™s Horizon 2020 research and 
innovation programme under grant agreement No 874707 (EXIMIOUS), Wellcome Investigator Award, 222442/A/21/Z and
UKRI Proactive Vaccinology Award, MR/Y004450/1 (IMMPROVE).
